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JGIM
analysis, the professional guidelines were compared to the departmental
OHNS recommendations to PCPs.
RESULTS: In 44.3% of the preoperative evaluations, tests were ordered in
excess of professional guidelines. We discovered that the departmental OHNS
recommendations conflicted with professional guidelines; for example, OHNS
advises obtaining an ECG on any patient over the age of 50, although
guidelines do not endorse routine age-based preoperative ECG testing.
CONCLUSIONS: Preliminary evidence demonstrates that preoperative
testing exceeds professional guidelines. Next steps include reconciling
departmental OHNS recommendations with professional guidelines,
identifying the reason(s) for guideline discordance in clinical practice,
and then intervening accordingly in order to prevent patient harm and
reduce healthcare costs.
LEARNING OBJECTIVE #1: Systems-Based Practice: Discuss the importance of guideline concordance in preoperative evaluation as it pertains to
individual patients and high-value healthcare.
LEARNING OBJECTIVE #2: Practice-Based Learning and Improvement: Describe how preoperative testing in clinical practice compares to
professional guidelines.
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BACKGROUND: In the United States, traumatic brain injury (TBI) is a
significant cause of morbidity and mortality. TBI rates have steadily risen
since 2006, and annual healthcare expenses in the United States are estimated
at $35 billion. Thus, prediciting which patients with TBI will have poor
outcome(s) will optimize decision making, patient care, and improve resource
utilization. This study sought to develop and validate a clinical tool for
predicting prolonged hospital stay (PROHOSP) in adults after TBI.
METHODS: Data was collected for adults (≧18 years) from the National
Trauma Data Bank from years 2007-2015. Patients who presented with any
TBI who survived emergency department admission were included. Our goal
was to use clinical variables that can readily measured upon arrival to the
emergency room (ER). As such, the predictors included patient demographics,
mechanism and intent of injury, vital signs, mode of transportation, respiratory
status, time from injury to ER arrival, Glasgow Coma Score (GCS), and Injury
Severity Score (ISS). Multivariable logistic regression was used to investigate
associations between predictive variables and PROHOSP. The samples were
split into a training set (70%) and a test set (30%). Model performance was
measured using the C-statistic and accuracy [(true positive + true negative)/
patient population]. Furthermore, we conducted a calibration curve to assess
the accuracy between estimated and observed number of outcome events.
RESULTS: In total, 484,775 adults were included in the study (67% male;
median [IQR] age, 54.0 [34.0, 73.0.] years; 78% White). The number of patients
who fell under PROHOSP category was n=127,912 (26.4%). PROHOSP patients more often had GCS 3 (26% vs 4.2%, p<0.001), were victims of motor
vehicle trauma (51% vs 35%, p<0.001), were transported via helicopter to the ER
(28% vs 14%, p<0.001), had a higher ISS (22 vs 16, p<0.001). The final model
consisted of 12 variables; the C-statistic of 80.5% (95% CI, 80.2% - 80.7%),
accuracy of 80.3%, sensitivity of 70.8%, and specificity of 82.1%.
CONCLUSIONS: This study provides an accurate and well-calibrated early
predictive model for PROHOSP in TBI patients. Lastly, we translated our
findings to develop a web application that is user- friendly for healthcare
providers in trauma centers.
LEARNING OBJECTIVE #1: Through the lens of patient care, this study
sought to develop a model that could predict PROHOSP in TBI patients. We
hope that our model would allow clinicians and families to more easily reach
consensus during medical decision-making for TBI patients. With time, the
goal would be to improve TBI outcomes nationwide.
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LEARNING OBJECTIVE #2: This study sought to raise awareness about
the soceital burden of TBI. We hope our predictive model can be seen as
systems-based practice that helps conserve healthcare resources, streamline
care, and increase positive outcomes.
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BACKGROUND: Diabetes mellitus affects 13% of American adults. To
address the complex care requirements necessary to avoid diabetes-related
morbidity, the American Diabetes Association recommends utilization of
multidisciplinary teams. Research shows pharmacists have a positive impact
on multiple clinical diabetic outcomes. We aimed to determine impact of an
education-focused pharmacist managed diabetes clinic model (PMDC) on
hemoglobin A1c (HbA1c) and other diabetes core measures at 6 and 12
months follow-up.
METHODS: Open-label randomized controlled trial with 1:1 allocation.
Patients 18-75 years old with type 2 diabetes mellitus and most recent HbA1c
≥9% were enrolled from a single institution resident- run outpatient medicine
clinic. Standard of care (SOC) patients continued with routine follow up with
their primary provider whereas the PMDC group had an additional 6 visits with
the pharmacist within 6 months from enrollment. Patients were followed for 12
months from enrollment. Data collected included HbA1c, lipid panel, statin
use, blood pressure control, immunization status for influenza and pneumonia,
and evidence of diabetic complications (retinopathy, nephropathy, neuropathy). Data analysis was done in the intention-to-treat and per-protocol
populations.
RESULTS: Forty-two patients were enrolled in the PMDC group and 44
patients in the SOC group. Three patients dropped out (2 patients from the
PMDC group and 1 patient from the SOC group). Average decrease in HbA1c
for the intervention compared to the control group at 6 months was -2.99% vs.
-1.01%, (p = 0.0021). (Figure 1) Additionally, the odds of achieving a goal
HbA1c of ≤8% at 6 months was 3.03 (95% CI= 1.01, 9.12, p= 0.0488) in the
intervention versus control group. There was no statistically significant difference in the remaining secondary outcomes measured. Missing data during
follow up limited power of secondary outcomes analyses.
CONCLUSIONS: Addition of pharmacist-managed care for patients with
type 2 diabetes mellitus is associated with significant improvements in HbA1c
compared with standard of care alone.
LEARNING OBJECTIVE #1: Medical Knowledge: To acquire knowledge
regarding the treatment of high-risk diabetes mellitus patients, and applying
this knowledge in patient care and in the education of others
LEARNING OBJECTIVE #2: 2. Patient Care: To assist in making informed decisions about the therapeutic options for the treatment of high-risk
diabetes mellitus patients based on scientific evidence

Figure 1: HbA1c values in Intent-to-Treat Population

